Dongsheng Xu

Dongsheng Xu


Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 February 2022 in Frontiers in Cardiovascular Medicine
Verified
Journal Article
Open access
HSHuikai Shao
Huikai Shao
YHYang Huang
Yang Huang
DXDongsheng Xu
Dongsheng Xu
SHShengfeng Huang
Shengfeng Huang
RTRong sheng Tong
Rong sheng Tong
Background: As adjunctive therapy, puerarin injection has been widely applied for the treatment of unstable angina pectoris (UAP) in China during the past decades. However, the efficacy of puerarin injection as adjunctive therapy for UAP has not been well confirmed. The purpose of this meta-analysis was to summarize the available evidence to estimate the efficacy of puerarin injection in treating UAP.Objective: A systematic review and meta-analysis with subgroup analysis and sensitivity analysis according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) principle were carried out to evaluate the efficacy of puerarin injection as adjunctive therapy in treating UAP.Methods: To obtain the published randomized controlled trials (RCTs) on puerarin injection, databases, namely, China National Knowledge Infrastructure (CNKI), Wanfang Database, Chinese Biomedical Literature Database, Sino-Med, PubMed, China Science and Technology Journal Database (VIP), Medline, Google Scholar, Cochrane Library, Chinese Science Citation Database, and Embase were systematically searched until June 2021. In this meta-analysis, Review Manager version 5.3 software and Stata version 12.0 software were employed to analyze the collected data. Based on the methodological quality, years of publications, sample size and dosages, sensitivity analysis, and subgroup analysis were performed. The GRADE assessment was conducted by the software GRADEpro version 3.6 software.Results: A total of 17 RCTs involving 1,459 patients were included in this meta-analysis. Results indicated that puerarin injection as adjunctive therapy was more superior than conventional Western medicine alone in reducing angina symptoms [risk ratio (RR) = 1.22, 95% CI 1.16 to 1.28, Z = 8.11, p < 0.00001] and improving ECG (RR = 1.32, 95% CI 1.20 to 1.44, Z = 6.00, p < 0.00001), meanwhile reducing the frequency of angina attack [mean difference (MD) = −2.22, 95% CI −2.53 to −1.90, Z = 13.97, p < 0.00001] and the duration of angina attack (MD = −2.00, 95% CI −2.39 to −1.61, Z = 9.99, p < 0.00001) for the treatment of UAP. Results from the GRADE assessment suggested that the comprehensive quality of this evidence was low.Conclusion: This meta-analysis indicated that puerarin injection was more effective than using conventional Western medicine alone in the treatment of UAP. However, because of the low methodological quality of the included RCTs, more evidence was still needed to verify the efficacy of puerarin injection.

2 April 2024 in Journal of Chromatography A
Verified
Journal Article
Closed access
LLLiang Lai
Liang Lai
MZMengyao Zhang
Mengyao Zhang
TLTong Li
Tong Li
JQJiahuan Qu
Jiahuan Qu
DXDongsheng Xu
Dongsheng Xu
zhengjin jiangzhengjin jiang
zhengjin jiang

27 August 2024 in Journal of Chromatography A
Verified
Journal Article
Closed access
LLLiang Lai
Liang Lai
MZMengyao Zhang
Mengyao Zhang
YCYuexiang Chang
Yuexiang Chang
MLMinyi Li
Minyi Li
JCJacques Crommen
Jacques Crommen
zhengjin jiangzhengjin jiang
zhengjin jiang

30 March 2025 in Journal of Chromatography A
Verified
Journal Article
Closed access
LLLiang Lai
Liang Lai
HLHongying Lan
Hongying Lan
HHHui Huang
Hui Huang
TLTong Li
Tong Li
KAKesara Ar-Sanork
Kesara Ar-Sanork
zhengjin jiangzhengjin jiang
zhengjin jiang

1 October 2025 in Frontiers in Chemistry
Verified
Journal Article
Open access
PDF file
YWYuanyuan Wu
Yuanyuan Wu
HHHui Huang
Hui Huang
XZXianglong Zhao
Xianglong Zhao
JLJunhao Lin
Junhao Lin
JGJialiang Guo
Jialiang Guo
DXDongsheng Xu
Dongsheng Xu
Traditional Chinese medicine (TCM), with a history spanning over 2,000 years, contains numerous strongly polar components that are increasingly the focus of pharmaceutical and analytical research. However, conventional reversed-phase liquid chromatography usually fails to adequately retain and separate these highly polar components. Hydrophilic interaction liquid chromatography (HILIC) has emerged as a powerful complementary technique, offering improved retention and separation for polar analytes. In recent years, HILIC has seen rapid development and wide application in the analysis of TCM. This review summarizes the major types of HILIC stationary phases and their recent applications in the separation of polar components in TCM. Particular attention is given to the analysis, quality control, and metabolomic profiling of bioactive compounds such as flavonoids, alkaloids, and saponins, highlighting the increasingly important role of HILIC in promoting TCM research.

16 October 2023 in Analytical Sciences
Verified
Journal Article
Closed access
PDF file
LLLiang Lai
Liang Lai
MZMengyun Zhang
Mengyun Zhang
CLChusheng Liu
Chusheng Liu
JQJiahuan Qu
Jiahuan Qu
DXDongsheng Xu
Dongsheng Xu
zhengjin jiangzhengjin jiang
zhengjin jiang